Novel Durysta improves compliance for treatment of glaucoma.
Sustained release technology solves an old treatment issue—patients who don’t take their medicine or don’t take it properly.
Durysta
was approved by the FDA in March of this year to deliver medication to control open-angle glaucoma. It is the first implantable sustained-release delivery system for reducing intraocular pressure.
Biodegradable Implant for the Eye
Durysta i (Read more...)